Long-haul covid and chronic Lyme disease are surprisingly similar

An experimental antibiotic treatment for Lyme disease, developed by Northeastern professor Kim Lewis, heads for human safety trials this spring. Results are anticipated by fall.

New infection and immunity center at Yale looks into long COVID-19, chronic Lyme disease

Revolutionary “Subway Map” Illuminates New Treatment Targets for Lyme Disease